Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Firestein

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Research|May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline gliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Cell|March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunitiesClaire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Research|May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline gliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Cell|March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunitiesClaire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 7